Scientific research, the increasing countries that have legalized cannabis and the diffusion of information, have favored the medicinal use of cannabis.
Although there are not many yet, there are several drugs derived from the cannabis plant and more and more pharmaceutical companies are aiming to produce drugs with this component, very useful in the treatment of certain diseases.
Derived from this situation arises the need to design facilities adapted to the production of drugs made with medical cannabis. At Albian Group, we put at your disposal all our knowledge in the area.
Leave your project in the hands of Albian Group; we will guarantee that the facilities designed by our team comply with GMP regulations and that the pharmaceutical products produced in them are suitable for the market.
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Palobiofarma S.L. is pleased to announce the “last patient last visi...
